The Cancer Genome Computational Analysis (CGCA) group — a central component of the Broad Institute’s Cancer Program — addresses unanswered questions of cancer biology and genomics through the development of computational methods and tools, in conjunction with platforms, datasets and resources. Specifically, the group works to understand cancer by characterizing and interpreting genomic data:
CGCA works closely with many groups within the Broad, including the institute’s Genomics, Genetic Perturbation, and Data Sciences platforms. CGCA members also engage with collaborators from the Broad’s partner institutions and outside organizations such as IBM. The team also participates in several National Institutes of Health-funded national consortia, such as The Cancer Genome Atlas (TCGA), the Genomic Data Analysis Network, the Clinical Proteomic Tumor Analysis Consortium, the Genotype-Tissue Expression (GTEx) Consortium.
The CGCA team has created a number of powerful genomic analysis tools and platforms for the cancer research community, including:
CGCA has also built and maintains several key genomic data resources, such as:



